Maximus (NYSE:MMS) Upgraded at Raymond James

Raymond James upgraded shares of Maximus (NYSE:MMS) from a market perform rating to an outperform rating in a research report sent to investors on Thursday, MarketBeat.com reports. They currently have $90.00 price objective on the health services provider’s stock.

Separately, StockNews.com downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research report on Friday, December 27th.

Maximus Stock Up 2.2 %

Shares of MMS opened at $77.50 on Thursday. The company has a 50-day moving average price of $77.76 and a two-hundred day moving average price of $85.26. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.59. The stock has a market cap of $4.67 billion, a price-to-earnings ratio of 15.50 and a beta of 0.73. Maximus has a 12 month low of $69.72 and a 12 month high of $93.97.

Insider Transactions at Maximus

In related news, Director Raymond B. Ruddy bought 3,490 shares of the company’s stock in a transaction that occurred on Thursday, December 12th. The shares were bought at an average price of $71.46 per share, for a total transaction of $249,395.40. Following the transaction, the director now directly owns 112,520 shares of the company’s stock, valued at approximately $8,040,679.20. The trade was a 3.20 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Michelle F. Link sold 2,208 shares of the stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the transaction, the insider now directly owns 6,567 shares in the company, valued at approximately $484,841.61. This represents a 25.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders acquired 7,063 shares of company stock valued at $502,017. Corporate insiders own 1.40% of the company’s stock.

Hedge Funds Weigh In On Maximus

Several institutional investors have recently made changes to their positions in the stock. V Square Quantitative Management LLC bought a new stake in Maximus in the 3rd quarter valued at about $25,000. Archer Investment Corp grew its stake in Maximus by 8,788.9% in the second quarter. Archer Investment Corp now owns 800 shares of the health services provider’s stock valued at $69,000 after acquiring an additional 791 shares during the period. GAMMA Investing LLC increased its holdings in shares of Maximus by 150.6% during the third quarter. GAMMA Investing LLC now owns 862 shares of the health services provider’s stock valued at $80,000 after acquiring an additional 518 shares in the last quarter. Ariadne Wealth Management LP acquired a new position in shares of Maximus during the second quarter worth approximately $90,000. Finally, Quarry LP lifted its holdings in shares of Maximus by 48.0% in the 3rd quarter. Quarry LP now owns 1,017 shares of the health services provider’s stock worth $95,000 after purchasing an additional 330 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.